Velg regionen som passer best for din plassering eller dine preferanser.
Denne innstillingen kontrollerer språket for brukergrensesnittet, inkludert knapper, menyer og all tekst på nettstedet. Velg ditt foretrukne språk for best brukeropplevelse.
Velg språkene for stillingsannonser du vil se. Denne innstillingen bestemmer hvilke stillingsannonser som vises for deg.
BIOASTER is the only health-related Technology Research Institute (TRI) in France selected by the General Commission for Investments [Commissariat Général à l’Investissement] as part of its Investment for the Future [Programme des Investissements d’Avenir] program. The BIOASTER project is a joint initiative with Lyonbiopole (international competitiveness cluster) and Institut Pasteur. BIOASTER was established as a Foundation for Scientific Cooperation (FSC) based on an innovative public/private partnership model. It offers a novel approach to R&D based on integrating several scientific and technological disciplines. BIOASTER conducts independent and collaborative interdisciplinary R&D activities on the frontier between basic and industrial development to ensure optimal alignment between research and innovation in the fields of infection diseases and microbiology and expand our understanding of intestinal microbiota and its impact on health